| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.649 | 13.979 | 13.444 | 10.057 | 11.211 | 8.327 | 8.785 | 7.493 | 6.318 | 6.932 |
| Total Income - EUR | 12.649 | 13.979 | 13.444 | 10.057 | 11.211 | 8.327 | 8.785 | 7.493 | 6.318 | 6.932 |
| Total Expenses - EUR | 8.972 | 10.564 | 8.905 | 8.572 | 10.315 | 8.107 | 5.852 | 11.391 | 6.016 | 6.680 |
| Gross Profit/Loss - EUR | 3.677 | 3.416 | 4.539 | 1.485 | 896 | 221 | 2.933 | -3.899 | 302 | 252 |
| Net Profit/Loss - EUR | 3.298 | 2.988 | 3.623 | 1.183 | 559 | 41 | 2.933 | -4.077 | 250 | 214 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - S&B Universal Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 7.571 | 6.657 | 13.109 | 16.324 | 14.114 | 12.806 | 11.033 | 18.858 | 14.985 | 11.472 |
| Inventories | 7.515 | 6.193 | 4.669 | 4.204 | 2.328 | 1.218 | 9.587 | 6.899 | 8.171 | 5.405 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31 | 35 |
| Cash | 56 | 463 | 8.441 | 12.120 | 11.786 | 11.588 | 1.446 | 11.959 | 6.783 | 6.032 |
| Shareholders Funds | -18 | 2.970 | 6.543 | 7.606 | 8.019 | 7.907 | 10.665 | 6.621 | 6.850 | 7.026 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.589 | 3.687 | 6.566 | 8.718 | 6.096 | 4.899 | 369 | 12.237 | 8.135 | 4.446 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4719
|
|||||||||
Comments - S&B Universal Med Srl